首页> 外文期刊>Environmental and Experimental Biology >Evaluation of morphological differences of breast cancer cells using various biological markers and the Feulgen method
【24h】

Evaluation of morphological differences of breast cancer cells using various biological markers and the Feulgen method

机译:使用多种生物学标记和Feulgen方法评估乳腺癌细胞的形态学差异

获取原文
       

摘要

Cancer cell nuclei have undergone chromatin structure condensation and changes in shape, nucleolus volume and staining properties. Nevertheless, it has been suggested that cancer stem cells are responsible for resistance to anticancer treatment and tumour recurrence. The aim of the study was to evaluate morphological differences and distribution of DNA amount in luminal and triple negative breast cancer cell populations using various biological markers and the Feulgen method. Multiple cell surface antigens like CD44 (the cluster of differentiation 44), CD24 (the cluster of differentiation 24), aldehyde dehydrogenase (ALDH) and nucleus antigens like embryonic stem cell marker (Oct3/4) can be used to identify cancer stem cells. Strong expression of antibody CD44 and ALDH and positive expression of CD24 and Oct3/4 were seen in both breast cancer groups among morphologically different cells. Amount of DNA indicated variability of cells. The study showed similarity between development and behaviour of microcells and polyploid cells, and we suggest that polyploid cells are in a later phase of development after anticancer treatment.
机译:癌细胞核已经发生了染色质结构浓缩和形状,核仁体积和染色特性的变化。然而,已经提出,癌症干细胞对抗癌治疗和肿瘤复发负有责任。这项研究的目的是使用各种生物标记和Feulgen方法评估管腔和三阴性乳腺癌细胞群体的形态学差异和DNA量的分布。多种细胞表面抗原,例如CD44(分化簇44),CD24(分化簇24),醛脱氢酶(ALDH)和细胞核抗原(如胚胎干细胞标记物(Oct3 / 4))可用于鉴定癌症干细胞。在形态不同的两个细胞中,两个乳腺癌组中均观察到抗体CD44和ALDH的强表达以及CD24和Oct3 / 4的阳性表达。 DNA的量表明细胞的可变性。该研究表明微细胞和多倍体细胞的发育和行为之间存在相似性,我们建议多倍体细胞在抗癌治疗后处于发育的后期。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号